Metoprolol Accord

Metoprolol Tartrate, the active ingredient in Metoprolol Accord, is a beta‑adrenergic blocker presented as an oral dosage form for oral use. It lowers blood pressure, relieves angina and improves outcomes in heart failure and certain cardiac arrhythmias.\n\nGNH India supplies Metoprolol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprolol Accord is a selective β1‑adrenergic blocker used in several cardiovascular conditions.\n\n- Hypertension: lowers systemic blood pressure by reducing heart rate and cardiac output.\n- Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.\n- Post‑myocardial infarction: improves survival by limiting cardiac workload and arrhythmias.\n- Chronic heart failure: enhances ventricular function and reduces hospitalization risk.\n- Cardiac arrhythmias (e.g., supraventricular tachycardia): slows conduction through the AV node, helping to control heart rhythm.

Metoprolol Accord may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Fatigue: feeling of tiredness or lack of energy.\n- Dizziness or light‑headedness, especially on standing.\n- Bradycardia: slower than normal heart rate.\n- Cold extremities: reduced peripheral circulation.\n- Gastrointestinal upset: nausea, abdominal discomfort.\n- Depression or mood changes.\n\nSerious or Rare Side Effects:\n- Severe bradycardia or heart block requiring medical attention.\n- Marked hypotension leading to fainting.\n- Bronchospasm or worsening asthma symptoms.\n- Acute heart failure exacerbation.\n- Allergic reactions such as rash, itching or angioedema.\n- Cardiogenic shock in rare cases.

Before initiating Metoprolol Accord, several safety considerations are recommended.\n\n- Monitor blood pressure: check regularly to ensure therapeutic control.\n- Assess heart rate: watch for excessive slowing or irregular rhythm.\n- Use caution in asthma or chronic obstructive pulmonary disease: β1‑selectivity may not fully prevent bronchospasm.\n- Avoid abrupt discontinuation: taper dose to prevent rebound hypertension or tachycardia.\n- Adjust dose in renal impairment: evaluate renal function and modify dosing as needed.\n- Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol Accord can interact with several medicines; awareness of major and moderate interactions helps maintain safety.\n\nMajor Interactions (Avoid):\n- Concomitant use with other AV‑nodal blockers (e.g., verapamil, diltiazem) may cause profound bradycardia.\n- Co‑administration with non‑selective β‑blockers or high‑dose calcium channel blockers can lead to severe hypotension.\n- Abrupt withdrawal of clonidine while on Metoprolol may precipitate hypertensive crisis.\n\nModerate Interactions (Monitor Closely):\n- NSAIDs may blunt antihypertensive effect, requiring dose adjustment.\n- Diuretics can enhance hypotensive response; monitor electrolytes.\n- Certain antidepressants (e.g., SSRIs) may increase plasma Metoprolol levels.\n- Antidiabetic agents may mask hypoglycemia symptoms; observe glucose closely.